Blood eosinophils have less of a role in predicting exacerbations or guiding treatment in mild asthma than in severe asthma, according to an analysis from the multinational Novel START study. The study comprised 675 adults with mild asthma, from 16 centres across four countries including Australia, who were using only a SABA such as salbutamol ...
Professor Helen Reddel: eosinophils of less use for guiding treatment in mild asthma
By Mardi Chapman
18 Mar 2020